Sales Growth YoY (Last Twelve Months): MiMedx Corp (MDXG)

Graphic logo of MiMedx Group, Inc. (MDXG)

MiMedx Group, Inc. (MDXG) dominates the tissue regeneration segment thanks to its unique bio-patches, although it faces pressure from synthetic alternatives and insurance risks. The sales dynamics over the last 12 months compared to the previous year help assess business resilience, where the current level equals -22.50. A positive trend is supported by the development of the EpiFix product line and the introduction of innovative allografts for healing complex wounds.

Sales Growth YoY (Last Twelve Months): MiMedx Group (MDXG) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for MiMedx Group Inc (MDXG)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:MDXG MiMedx Corp
Mass-produced product of MiMedx

This indicator measures revenue dynamics over the last twelve months, filtering out short-term market fluctuations to identify the actual business scaling trend. Analyzing the last twelve months (LTM) revenue growth rate allows for stress-testing the portfolio for asset overpayment, confirming that the growth of MiMedx Group, Inc. (MDXG) is driven not by random spikes, but by the effective commercialization of products supported by a strong R&D core.

Competitors of MiMedx Group, Inc. (MDXG)

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)